Introduction
============

Axons are indispensable for neuronal function but degenerate early in nervous system disorders ([@bib15]). Distal stumps of injured axons undergo Wallerian degeneration ([@bib34]), a regulated, nonapoptotic death program that models disease processes ([@bib12]).

The slow Wallerian degeneration (*Wld^S^*) gene dominantly delays Wallerian degeneration 10-fold ([@bib28]; [@bib19]; [@bib33]; [@bib12]). *Wld^S^* was identified by positional cloning ([@bib13]; [@bib14]) and replicates the protective phenotype in transgenic (Tg) mice ([@bib28]), rats, and *Drosophila melanogaster* ([@bib1]; [@bib22]; [@bib26]). It fuses the N-terminal 70 amino acids (N70) of multiubiquitination factor Ube4b in frame to the NAD^+^-synthesizing enzyme nicotinamide mononucleotide adenylyl transferase 1 (Nmnat1), separated by a short Wld18 linker sequence. The parent proteins are unchanged. Wld^S^ also delays axon degeneration in some diseases indicating similar mechanisms, particularly when axonal transport is blocked ([@bib12]).

Understanding how Wld^S^ protects axons should help exploit its therapeutic potential and reveal the degenerative mechanism. In this study, we address the protein domains required in vivo and their roles. Overexpressing Nmnat1 in Tg mice is not sufficient to protect axons ([@bib16]), but in lentiviral-transduced primary culture, protection has been reported ([@bib2]; [@bib35]). Thus, the N-terminal 88 amino acids are required in vivo, and primary culture experiments do not replicate the protective mechanism fully. However, the specific necessary sequences and their roles remain unknown. Moreover, reports that Nmnat1 blocks other types of neurodegeneration in vivo without enzyme activity contrasts with primary culture data on axon degeneration, so a classical mammalian in vivo approach is needed to resolve this ([@bib2]; [@bib41]).

N70 binds AAA ATPase valosin-containing protein (VCP) through a VCP-binding motif (VBM) in its N-terminal 16 amino acids (N16; [@bib8]; [@bib29]). In nuclei, in which Wld^S^ is most easily visualized, VCP influences local Wld^S^ targeting ([@bib38]). Recent data indicate that Wld^S^ can function in cytoplasm ([@bib6]), in which VCP is extremely abundant. Thus, VCP interaction also likely affects local targeting of cytoplasmic Wld^S^.

Early embryonic lethality precludes testing a role for VCP in null mice ([@bib30]). Thus, we generated Tg mice expressing variant Wld^S^ with altered VCP-binding properties and lesioned their nerves. In view of the controversies over Nmnat activity, we also generated enzyme-dead Tg mice.

Results and discussion
======================

Variant Wld^S^ Tg mice with an altered VCP-binding region
---------------------------------------------------------

First, we tested the need for the VCP-binding sequence, expressing Wld^S^ without amino acids 2--16 in ΔN16Wld^S^ Tg mice (Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200807175/DC1>). Two of the four lines expressed protein on brain Western blots ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib33]). Line 1 homozygotes expressed similar levels to *Wld^S^* heterozygotes. Line 2 could not breed to homozygosity. Hemizygotes expressed slightly less, but still at a level where Wld^S^ delays axon degeneration significantly ([@bib28]). Nmnat activity matched or exceeded that in Wld^S^ ([Fig. 1 E](#fig1){ref-type="fig"}), and lumbar spinal cord motor neurons, whose axons in the sciatic nerve we lesioned, express the protein ([Fig. 1 D](#fig1){ref-type="fig"}). The ΔN16Wld^S^ variant showed a clear cytoplasmic signal, with no significant difference in nuclear/cytoplasmic distribution relative to Wld^S^ at *n* = 3 ([Fig. 1, C and D, i--iv](#fig1){ref-type="fig"}).

![**Overexpression of ΔN16Wld^S^ and ATX3Wld^S^ in Tg mice.** (A and B) Western blots of ΔN16Wld^S^ and ATX3Wld^S^ brains probed with Wld18. ΔN16Wld^S^ lines 1 and 2 alone express a protein slightly smaller than Wld^S^. The 43-kD ATX3Wld^S^ band matches that in *Wld^S^*. (C) Brain Western blots of total homogenate and nuclear and cytoplasmic fractions of *Wld^S^*, ΔN16Wld^S^ (line 1), and ATX3Wld^S^ (line 6). The graph shows integrated band intensities of nuclear and cytoplasmic fractions normalized to H1 and β-actin, respectively. These normalized figures were then expressed as a percentage of the total homogenate signal and normalized to the same respective markers (mean ± SD; *n* = 3). Statistical analysis was performed on the nuclear versus supernatant ratio using a Mann-Whitney test followed by a Bonferroni post-hoc test. (D) Immunofluorescence of lumbar spinal cord sections with Wld18 (red) and DAPI. Motor and interneuron nuclear signals in Tg ΔN16Wld^S^ (i--iv) and ATX3Wld^S^ (v--viii) show similar strength and distribution as *Wld^S^* heterozygotes. Identical laser intensities and camera settings were used for each image. (E and F) Transgene products are enzymatically active. Nmnat activity is very significantly increased compared with wild-type (WT) brains in hemizygotes and homozygotes of all expressing Tg lines as well as *Wld^S^* heterozygotes. Mean ± SD; \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. Bars, 10 µm.](JCB_200807175_RGB_Fig1){#fig1}

We then replaced N16 with a 16--amino acid VCP-binding sequence from polyglutamine protein ataxin-3 (Atx-3; 277--291 plus start Met, ATX3) sharing only five residues (Fig. S1; [@bib8]). At least 5 of 12 lines expressed protein, and most experiments used line 1 and 6 homozygotes. Again, we confirmed protein expression and enzyme activity similar to or exceeding Wld^S^ heterozygotes ([Fig. 1](#fig1){ref-type="fig"}). Despite some variability, subcellular localization of ATX3Wld^S^ was not significantly different from Wld^S^ or ΔN16Wld^S^ (*n* = 3; [Fig. 1 C](#fig1){ref-type="fig"}), and the protein was in neuronal nuclei in the lumbar spinal cord ([Fig. 1 D, v--vii](#fig1){ref-type="fig"}).

Effect of the VCP-binding region on phenotype
---------------------------------------------

5 d after sciatic nerve lesion, *Wld^S^* heterozygotes retained 69.7 ± 1.8% of axons with normal cytoskeleton, unswollen mitochondria, and a regular myelin sheath of normal thickness compared with only 1.2 ± 0.4% in wild-type mice ([Fig. 2](#fig2){ref-type="fig"} and Fig. S1). In contrast, ΔN16Wld^S^ was indistinguishable from wild type. Line 1 homozygotes and line 2 hemizygotes showed 2.3 ± 0.2% and 0.9 ± 0.2% surviving axons, respectively ([Fig. 2, a--d](#fig2){ref-type="fig"}; and Fig. S1). Axons lost continuity, as assessed by crossing to YFP-H Tg mice ([@bib5]), by 3 d ([Fig. 2, g and h](#fig2){ref-type="fig"}), which is a low stringency test ruling out even a weak protective phenotype. Axons in *Wld^S^* heterozygotes maintain continuity even at 5--14 d ([Fig. 3](#fig3){ref-type="fig"}). Finally, ultrastructural experiments confirmed that axons of ΔN16Wld^S^ mice retained little, if any, normal cytoskeleton and organelles after 3 d ([Fig. 2, i--l](#fig2){ref-type="fig"}). Thus, N16, which contains a VBM, is essential for Wld^S^ to delay Wallerian degeneration.

![**Rapid Wallerian degeneration in ΔN16Wld^S^ Tg mice.** (a--d) Semithin sections of distal sciatic nerve 5 d after lesion. (a) Axons are well preserved in *Wld^S^* heterozygotes, with intact myelin sheaths, uniform and regularly spaced cytoskeleton, and normal-shaped mitochondria. (b) Wild-type axons are degenerated, with collapsed myelin and disorganized or vacuolized cytoskeleton. (c and d) ΔN16Wld^S^ line 1 homozygous and line 2 hemizygous nerves are indistinguishable from wild type. (e--h) Tibial nerves from mice crossed to YFP-H show rapid loss of axon continuity in ΔN16Wld^S^. (e) *Wld^S^* heterozygotes 3 d after lesion show axon continuity. (f--h) In contrast, all lesioned wild-type and ΔN16Wld^S^ line 1 and line 2 axons lose continuity within 72 h. (i--l) Transmission electron microscopy of distal sciatic nerve 3 d after lesion. (i) Myelinated and unmyelinated axons are well preserved in *Wld^S^* heterozygotes, which are indistinguishable from unlesioned nerves (l). (j) In wild type, myelin collapsed to form ovoids, the cytoskeleton is floccular or absent, and mitochondria are swollen or absent. (k) Nerves from ΔN16Wld^S^ line 1 homozygotes are indistinguishable from wild types. Bars: (a--d) 20 µm; (e--h) 50 µm; (i--l) 2 µm.](JCB_200807175_RGB_Fig2){#fig2}

![**ATX3Wld^S^ Tg mice show a Wld^S^ phenotype.** (A, i--iv) Semithin sections of distal sciatic nerve 5 d after lesion. (i and ii) Most axons are well preserved in *Wld^S^* heterozygotes (i), but wild-type nerves (ii) are completely degenerated. (iii and iv) Nerves from ATX3Wld^S^ line 1 and line 6 show preservation similar to *Wld^S^* heterozygotes. (v--viii) Confocal images of tibial nerve 5 d after sciatic lesion from mice crossed to YFP-H. (v) *Wld^S^* heterozygotes maintain axon continuity. (vi) All wild-type axons are highly fragmented. (vii and viii) Many lesioned ATX3Wld^S^ axons maintain continuity. (B, i, iii, and iv) Semithin sections of distal sciatic nerve show preserved axons (arrowheads) 14 d after lesion in *Wld^S^* heterozygotes (i) and ATX3Wld^S^ (iii and iv). (ii) Wild-type axons are completely degenerated and highly vacuolized. (v--viii) Confocal images of tibial nerves 14 d after sciatic nerve lesion in mice crossed to YFP-H. (v) *Wld^S^* axons maintain continuity in contrast to the few remnants of the fragmented wild-type axons (vi). (vii and viii) Many axons in ATX3Wld^S^ were also continuous at this stringent time point. Bars: (i--iv) 20 µm; (v--viii) 50 µm.](JCB_200807175_RGB_Fig3){#fig3}

Replacing the VCP-binding site with the Atx-3 sequence restored strong axon protection similar to *Wld^S^*. 5 d after nerve lesion, lines 1 and 6 showed highly significant structural preservation on semithin sections and retained axon continuity similar to *Wld^S^* heterozygotes ([Fig. 3 A](#fig3){ref-type="fig"} and Fig. S1). Axons in other lines were also protected (Fig. S2, available at <http://www.jcb.org/cgi/content/full/jcb.200807175/DC1>).

We then applied more stringent tests to verify that ATX3Wld^S^ mice have a full Wld^S^ phenotype. 14 d after sciatic lesion, distal axons on semithin sections were structurally preserved, as in *Wld^S^* (P \> 0.05). In whole-mount nerves, many YFP-H--labeled axons retained continuity ([Fig. 3 B](#fig3){ref-type="fig"} and Fig. S1). Little but debris remained in wild-type nerves. We then confirmed that lesioned axons and their neuromuscular synapses remained functional for at least 3 d. Evoked action potentials in tibial nerve/flexor digitorum brevis (FDB) preparations provoked robust contractile and electromyographic responses ([Fig. 4 A](#fig4){ref-type="fig"} and Video 1, available at <http://www.jcb.org/cgi/content/full/jcb.200807175/DC1>) that were absent in controls (Video 2). Immunostaining for preserved presynaptic structures of 3-d axotomized neuromuscular junction showed most endplates partially or fully occupied by motor nerve terminals connected to intramuscular motor axons ([Fig. 4 B](#fig4){ref-type="fig"}).

![**Functional motor innervation.** (A) ATX3Wld^S^ mice show robust preservation of neuromuscular function 3 d after nerve lesion. (i and ii) Isometric single twitch (i) and 20-Hz tetanic tension (ii) responses of isolated FDB to tibial nerve stimulation. (iii and iv) Averaged (16 sweeps) extracellular evoked EMG responses to stimulation of 3-d axotomized FDB from ATX3Wld^S^ (iii) and *Wld^S^* (iv). The x axis represents milliseconds, and the y axis represents millinewtons or microvolts. Bars: (i) 200 ms and 2 mN; (ii) 700 ms and 5 mN; (iii) 6 ms and 200 µV; (iv) 12 ms and 200 µV. (B) Confocal microscopy of axotomized FDB from an ATX3Wld^S^ line 5 mouse in which physiological recordings indicated robust preservation of neuromuscular function. Most motor endplates (TRITC--α-bungarotoxin staining; red) were innervated by neurofilament-positive axon collaterals and motor nerve terminals (green), but ∼20% of endplates were unoccupied. (i) Low power z-series projection. (ii and iii) Higher magnification images correspond to the boxed areas in panel i.](JCB_200807175_RGB_Fig4){#fig4}

We then treated spinal cervical ganglia (SCG) explants from these mice with vincristine to confirm these results using an assay in which axons are not cut ([@bib32]). As reported, Wld^S^ protected these axons ([@bib36]; [@bib16]). Consistent with our in vivo data, ΔN16Wld^S^ neurites degenerated at a wild-type rate, whereas ATX3Wld^S^ neurites remained largely intact 5 d after vincristine application (Fig. S2).

In summary, the Atx-3--derived VCP-binding sequence restores axon protective properties to ΔN16Wld^S^ that are indistinguishable from *Wld^S^* in terms of structure, long-term survival, and axonal and synaptic function. Collectively, these results strongly support a role of the VBM in Wld^S^-mediated axon protection.

Nmnat enzyme activity is required for the Wld^S^ phenotype
----------------------------------------------------------

Having shown that N16 is necessary for the Wld^S^ phenotype in mice, we then tested the requirement for Nmnat activity in vivo and whether N16 and other N-terminal sequences, including Wld18, are sufficient. We made Tg mice expressing enzyme-dead Wld^S^ (W258A; Fig. S1) but retaining all N-terminal sequences.

Tg-expressing lines 2 and 4 showed no increase in brain Nmnat activity over wild type, whereas activity in *Wld^S^* heterozygotes increased two- to threefold ([Fig. 5, A and C](#fig5){ref-type="fig"}). As before, we confirmed protein expression in motor neuron nuclei ([Fig. 5 B](#fig5){ref-type="fig"}) and we lesioned sciatic nerves. At the 3-d (low stringency) time point, homogeneous axoplasm and unswollen mitochondria could no longer be identified in semithin sections ([Fig. 5 D, i and ii](#fig5){ref-type="fig"}), and neither line retained axon continuity ([Fig. 5 D, v and vi](#fig5){ref-type="fig"}). The third expressing line showed similar wild-type--like behavior (unpublished data). In contrast, *Wld^S^* heterozygous mice expressing a similar level of Wld^S^ protein showed strong axon protection ([Fig. 5 D, iii](#fig5){ref-type="fig"}; and Fig. S1).

![**Rapid Wallerian degeneration in W258AWld^S^ Tg mice.** (A) Brain Western blots from W258AWld^S^ Tg, *Wld^S^*, and wild-type mice probed with Wld18. W258AWld^S^ lines 2 and 4 express a 43-kD band, which is absent in wild type. (B) Wld18 immunofluorescence (red) of lumbar spinal cord. Motor neuron nuclear signal strength and distribution in W258AWld^S^ lines match *Wld^S^* heterozygotes. Identical laser intensities and camera settings were used for each image. (C) Nmnat1 activity is unaltered in the W258AWld^S^ brain. (D, i and ii) Semithin sections of W258AWld^S^ distal sciatic nerve 72 h after lesion. Axons are degenerated, similar to wild-type or ΔN16Wld^S^ axons ([Fig 2](#fig2){ref-type="fig"}). (iii--vi) In mice crossed to YFP-H, tibial nerve axons lose continuity within 72 h of sciatic lesion, except in Wld^S^ (iii). (E) SCG explants untreated (i--iv) or treated (v--viii) with 100 nM FK866 for 72 h and then cut. Unlike wild-type axons (i, ii, v, and vi), untreated Wld^S^ axons are intact 72 h after being cut (iv) but when treated with FK866 are more degenerated (viii). (F) Quantification of continuous neurites (or neurite bundles). \*\*\*, P \< 0.0001 (one-way analysis of variance followed by Bonferroni post-hoc test); *n* = 8 (wild type \[WT\]) and 9 (*Wld^S^*). (G) NAD^+^ or NADP^+^ levels in wild-type and Wld^S^ explants ± FK866 at 1--100 nM. Mean of three different experiments. (C, F, and G) Mean ± SD. Bars: (B, D, i and ii, and E) 10 µm; (D, iii--vi) 100 µm.](JCB_200807175_RGB_Fig5){#fig5}

We confirmed rapid degeneration of injured W258AWld^S^ neurites in SCG explant cultures and added 1 mM exogenous NAD^+^ either 24 or 0 h before cutting. As we previously found in wild-type neurites ([@bib16]), neither treatment altered the rate of degeneration (Fig. S3 A, available at <http://www.jcb.org/cgi/content/full/jcb.200807175/DC1>). Although we cannot be sure how much NAD^+^ entered the cells, these data are consistent with the notion that N16 and Nmnat activity must be physically linked in the same molecule to deliver Nmnat activity to a specific site. Thus, an intact VCP-binding region in N16 is not sufficient to confer any Wld^S^ phenotype in vivo without associated Nmnat activity, nor is N70 or even N70 + Wld18.

To test the causal link between NAD^+^ production and axon protection, we then used FK866 to block the enzyme nicotinamide phosphoribosyltransferase. Nicotinamide phosphoribosyltransferase catalyzes the rate-limiting step for NAD^+^ salvage from nicotinamide. FK866 strongly reduced NAD^+^ or NADP^+^ levels in Wld^S^ SCG cultures ([Fig. 5 G](#fig5){ref-type="fig"}), and this was accompanied by a modest, partial reversion of the phenotype. Very few morphologically normal neurites remained in FK866-treated Wld^S^ cultures 72 h after cutting ([Fig. 5 E, vii and viii](#fig5){ref-type="fig"}), whereas significantly more intact neurites remained in untreated Wld^S^ cultures ([Fig. 5, E \[iii and iv\] and F](#fig5){ref-type="fig"}). After 6 d, there remained an obvious, statistically significant difference (Fig. S3 B). These data suggest that NAD^+^ synthesis is required for the Wld^S^ phenotype, but the incomplete reversion also suggests a need to consider other actions of Nmnat1 and/or other downstream metabolites. Alternatively, NAD^+^ may be tightly regulated at specific loci in a way that the whole cell measurements do not reflect.

Finally, we tested whether Nmnat1 chaperone activity contributes to axon protection by Wld^S^. Chaperone activity in the W258A mutant protein was similar to that reported for enzyme-dead Nmnat (*n* = 3; [@bib41]; and unpublished data), but as the mice show no axon protection, this is unlikely to be sufficient for the Wld^S^ phenotype.

By refining the N-terminal sequence needed for Wld^S^ protein to preserve injured axons in mice and showing that Nmnat enzyme activity is also required to protect axons in vivo, we conclude that Wld^S^ protects axons through a mechanism involving both of its parts. The absence of axon protection in ΔN16Wld^S^ mice confirms and extends our earlier data that Nmnat1 cannot substitute for Wld^S^ protein at a similar expression level ([@bib16]). The accompanying paper shows that the two proteins are also not equivalent in *Drosophila* (see Avery et al. on p. 501 of this issue). However, Nmnat activity is required, and in Wld^S^, it works together with the N-terminal VCP-binding sequence to protect axons. The function of N16 now holds essential clues as to where this enzyme activity is needed and why, and it will be interesting to find out whether other changes or additions to Nmnat1 can make it protective in vivo.

The only known biochemical property of N16 is binding VCP ([@bib25]). The VBM is highly conserved among vertebrates and some invertebrates ([@bib29]), including *Drosophila*, which could help explain how murine Wld^S^ can function there through a mechanism involving VCP ([@bib3]). At the cellular level, recent data indicate that Wld^S^ can function outside nuclei ([@bib6]), so we tested whether N16 binding to VCP (which is abundant in the cytoplasm as well as the nucleus) tethers some Wld^S^ in the cytoplasm. ΔN16 variant is abundant in cytoplasm ([Fig. 1 C](#fig1){ref-type="fig"}), indicating that the functional importance of N16 is not solely to retain the protein in the cytoplasm. Instead, we propose a finer targeting role. As N16 binding to VCP influences local targeting of Wld^S^ within nuclei ([@bib38]), it likely has a similar local effect in cytoplasm. Thus, the critical function of N16 may be local targeting of Nmnat1 to a cytoplasmic site where it is needed for axon protection.

Such a model may explain why overexpressing wild-type Nmnat1 without N16 fails to produce any Wld^S^ phenotype in Tg mice ([@bib16]), whereas overexpression in lentiviral-transduced cultures or in *Drosophila* does reproduce the phenotype to some extent ([@bib2]; [@bib22]; [@bib26]). In higher expressing systems with shorter axons, Nmnat1 may reach levels at which focal targeting becomes unnecessary. However, high Nmnat1 expression levels could also trigger unrelated mechanisms.

The local targeting model raises two important questions: what is the critical site, and what does Nmnat1 do there? A local bioenergetics mechanism for NAD^+^ within mitochondria has been proposed ([@bib35]). However, the ability of Wld^S^ to maintain axonal NAD^+^ and ATP levels could be an effect of axon survival rather than a cause, and how VCP binding and N16 fit such a model is not clear. Further investigations of VCP in mitochondria could shed light on this issue ([@bib9]). An alternative location that does connect VCP and NAD^+^ is the ER. VCP is particularly abundant here ([@bib40]), and NAD^+^ is a key upstream regulator of calcium signaling in this organelle through enzymes such as CD38 ([@bib27]).

NAD^+^ is also a substrate for the sirtuin family of histone deacetylases ([@bib39]) and for the ADP ribosylase PARP-1 ([@bib23]), and Nmnat protects against reactive oxygen species ([@bib31]). A Sirt1-mediated mechanism ([@bib2]) is not supported by subsequent data ([@bib35]; [@bib16]; [@bib3]), but these other possibilities remain plausible. However, a chaperone-mediated mechanism for axon protection ([@bib41]) is not supported by our data.

Other functions of VCP include roles in the cell cycle, homotypic membrane fusion, nuclear envelope reconstruction, postmitotic Golgi reassembly, DNA damage response, suppression of apoptosis, ER-associated protein degradation, and ubiquitin-dependent protein degradation ([@bib37]). Thus, if the critical function of N16 is binding to VCP, one or more of these sites could be important. VCP also has many associations with neurodegenerative disease as a component of intranuclear and cytoplasmic aggregates ([@bib24]), as the mutated gene in the rare neurological disorder inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia ([@bib37]), and through binding to Atx-3 and other polyglutamine proteins ([@bib21]; [@bib8]).

As there are no null or conditional null VCP mice, VCP-independent mechanisms cannot be tested further using in vivo mouse experiments. We cannot rule out a role for other amino acids in common between the Atx-3--derived VCP-binding sequence and N16 or an influence on Wld^S^ turnover. However, in *Drosophila*, where targeted RNAi in specific neurons overcomes lethality, VCP knockdown significantly weakens the Wld^S^ phenotype ([@bib3]). Collectively, these data strongly suggest that VCP binding is the critical property of this sequence that is required for the phenotype.

Like other chimeric proteins, Wld^S^ has a biological activity that requires both of its parts. In other cases, this can be the result of a conformational change that confers a new property such as affinity for a different receptor in the case of a ligand ([@bib11]). The combination of two different proteins to form a chimera often arises from chromosome translocations or gene duplications and has evolutionary relevance. Wld^S^ arose in the laboratory mouse, so it is not the result of generations of adaptive mutations. Nevertheless, this is another intriguing example of how protein domains can be combined to produce a completely new function.

The impressive correlation between the phenotypes of *Wld^S^* mice, rats, and *Drosophila*, each carrying the mouse cDNA, indicates that the degenerative pathway that it blocks is well conserved in evolution. Even in *Drosophila*, Nmnat1 cannot fully substitute for Wld^S^ in conferring axon protection, although a weak effect can be obtained from Nmnat1 overexpression alone, maybe reflecting higher expression levels reached in the fly with the use of a different promoter ([@bib26]; [@bib3]). VCP-binding sequences are required for the full Wld^S^ phenotype in *Drosophila* as well as in mice, and down-regulation of ter94, the *Drosophila* homologue of VCP, significantly weakens the phenotype ([@bib3]). These similarities validate *Drosophila* as a model to study axon degeneration and protection by Wld^S^ and demonstrate how *Drosophila* experiments can provide information not easily obtainable in the mouse.

In summary, we show that N16, which contains a VBM, is necessary for Wld^S^ to delay Wallerian degeneration, and this sequence acts together with Nmnat1 activity. In this study, we propose a new model for Wld^S^ action that explains the requirement of both N-terminal Ube4b-derived sequence and Nmnat1 enzyme activity. Having strongly implicated VCP binding in the protective mechanism and having shown that VCP binding helps direct the subcellular distribution of Wld^S^, we suggest that the role of the N-terminal region is to deliver Nmnat activity to an important, specific subcellular site. Further studies are necessary to identify this specific site and to understand what Nmnat1 does there to produce the Wld^S^ phenotype.

Materials and methods
=====================

Generation of Tg mice
---------------------

The ΔN16Wld^S^ Tg construct was generated as previously reported ([@bib28]; [@bib16]) using the forward PCR primer 5′-TAGCCC[AAGCTT]{.ul}TAGAGGAAAGCG[ATG]{.ul}CTTGCTGGTGGACAGACCTC-3′ (5′ HindIII tag and start codon underlined). For the ATX3Wld^S^ construct, the primer 5′-AGCCC[AAGCTT]{.ul}TAGAGGAAAGCG[ATG]{.ul}**ACTTCAGAAGAGCTTCGGAAGAGACGAGAAGCCTACTTGAAAAA*CTTGCTGGTGGACAGACCT***-3′ (5′ HindIII tag and start codon underlined, Atx-3 sequences in bold, and Wld^S^ sequences in bold and italic) and its reverse complement were annealed and mixed with linearized ΔN16Wld^S^. The mix was used as a template for PCR with the reverse primer that has been previously described ([@bib28]; [@bib16]) and the forward primer 5′-AGCCC[AAGCTT]{.ul}TAGAGGAAAGCG[ATG]{.ul}ACTTC-3′ (5′ HindIII tag and start codon underlined). For the W258AWld^S^ construct, tryptophan 258 of Wld^S^ was mutated to an alanine using the QuikChange Site-Directed Mutagenesis kit (Agilent Technologies) with the primer 5′-GCGTGCCCAACTTG[GCG]{.ul}AAGATGGAGGAC-3′ and its reverse complementary primer (W→A mutation underlined).

Pronuclear injection of the EcoRI--NdeI fragments (Fig. S1) into an F1 C57BL-CBA strain was performed by the in-house Gene Targeting Facility. Animal work was performed in accordance with the 1986 Animals (Scientific Procedures) Act under project licence PPL 80/1778.

Genotyping
----------

Tg mice were identified by Southern blotting as described previously ([@bib16]). YFP-H mice ([@bib18]) were obtained from The Jackson Laboratory and genotyped by Southern blotting (YFP probe generated by PCR from YFP-H mouse genomic DNA using the primers 5′-CGAACTCCAGCAGGACCATGTGAT-3′ and 5′-CTTCTTCAAGGACGACGGCAACTACAAG-3′).

Western blotting and Nmnat enzyme activity assay
------------------------------------------------

Western blotting and Nmnat enzyme activity assays of sagittally divided half brains were performed as described previously ([@bib16]). Subcellular fractionation of the nuclear and cytoplasmic compartments was performed as described previously ([@bib6]). For these experiments, *Wld^S^* heterozygotes, ΔN16Wld^S^ line 1, and ATX3Wld^S^ line 6 mice were used. In addition to Wld18 (1:2,000), mouse monoclonal anti--histone H1 (1:500; Millipore) and mouse monoclonal anti--β-actin (1:5,000; Abcam) were used as loading controls for the nuclear and the cytoplasmic fraction, respectively. All subcellular pellets were resuspended in the same volume as the starting total homogenate. Identical volumes of each fraction were loaded on the gels. For quantification, Western blot band intensities were determined with ImageJ software (National Institutes of Health) and analyzed as described in the figure legends.

Statistical analysis was performed using one-way analysis of variance followed by Dunnett's *t* post-hoc test or, when this was not applicable, by Kruskall-Wallis analysis followed by Mann-Whitney tests.

Immunocytochemistry
-------------------

20-µm cryostat lumbar spinal cord sections of 4% paraformaldehyde perfusion-fixed mice were immunostained for Wld18 and imaged as described previously ([@bib16]). Isolated FDB muscles were whole-mount immunostained for neurofilament and/or SV2, and acetylcholine receptors at motor endplates were counterstained with TRITC--α-bungarotoxin and imaged as described previously ([@bib20]).

Acquisition and processing of images
------------------------------------

Bright field images were acquired on a microscope (IX8I; Olympus) coupled to a digital camera (U-TV 0.5XC; Olympus) using AnalySIS software (Soft Imaging System, GmbH). The objectives used were UPlanFI 4× NA 0.13, UPLanFI 10× NA 0.3, LCPlanFI 20× NA 0.40 (all air objectives), and UPLanSApo oil immersion 100× NA 1.40. Confocal fluorescent images were acquired using a confocal microscope system (LSM 510 Meta; Carl Zeiss, Inc.) built around an Axiovert 200 (Carl Zeiss, Inc.), and z series were merged using algorithms from LSM Software Release 3.2 (Carl Zeiss, Inc.). For colocalization analysis, the multitrack configuration mode was applied to avoid signal cross talk between individual fluorophores. The objectives used were Plan-Neofluar 20× NA 0.5 and oil immersion Plan-Apochromat 63× NA 1.4. Tissue preparations were mounted in Vectashield medium (Vector Laboratories). The fluorophores used were YFP and Alexa Fluor 568. Nuclei were stained with DAPI. All images were acquired at room temperature.

Nerve lesion
------------

Mice were anaesthetized with a mixture of 100 mg/kg ketamine (Fort Dodge Animal Health) and 5 mg/kg xylazine (Pfizer). Right sciatic nerves were transected at the upper thigh, and mice were killed by cervical dislocation 72 h to 14 d later. The swollen first 2 mm of distal nerve was discarded, and the remaining sciatic nerve stump was used for light and electron microscopy (see following section). For YFP-H mice, the tibial nerve was removed for confocal microscopy.

Light and electron microscopy
-----------------------------

Nerves were fixed for at least 24 h in 0.1 M of phosphate buffer containing 4% paraformaldehyde and 2.5% glutardialdehyde, embedded in Durcupan resin (Fluka), and processed for light and electron microscopy as previously described ([@bib5]).

Electrophysiology
-----------------

Mice were killed by cervical dislocation. Isometric tension recordings and electromyography (EMG) were performed as described previously ([@bib4]; [@bib17]). Tibial nerve/FDB preparations were dissected, pinned to a Sylgard-lined dish, bathed in oxygenated mammalian physiological saline (137 mM Na^+^, 4 mM K^+^, 2 mM Ca^2+^, 1 mM Mg^2+^, 147 mM Cl, 5 mM glucose, and 5 mM Hepes, pH 7.2--7.4, equilibrated with 100% oxygen), connected either to a sensitive force transducer via their tendons or to a pair of stainless steel wires insulated within 500 µm of their tips, and inserted into the belly of the isolated muscle. The tibial nerve was stimulated using a suction electrode and tension, or EMG recordings were made on a laptop computer (Macintosh G4; Apple) using Chart version 4.1.1 (ADInstruments Ltd.) and Scope version 3.6.8 (ADInstruments Ltd.) software via a Powerlab 4/20T interface (ADInstruments Ltd.). Nerves were stimulated using 50--200-µs pulses, with 0.1--1-mA intensity at 1--20 Hz either from the Powerlab unit or using an isolated pulse stimulator (model 210; A-M Systems) supplying variable 1--10-V pulses for 200 µs in duration and at frequencies of 1--40 Hz. In some experiments, muscle contractions were also recorded as short videos through a dissecting microscope (Wild M5A; Spectra Services) using a digital camera (Coolpix 4500; Nikon).

Analysis of YFP-labeled nerves
------------------------------

Sciatic and tibial nerves were quickly removed from humanely killed mice, processed, and imaged as described previously ([@bib16]).

SCG explant cultures and NAD^+^ or NADP^+^ assay
------------------------------------------------

SCG explants were dissected, cultured, and lesioned as previously described ([@bib10]). Neurites were allowed to extend for 7 d in all cultures before any treatment. In vincristine experiments, this was used at a 0.02-µM final concentration, and the day of treatment was considered time 0. In experiments with FK866, the appropriate concentration was applied, and the cultures were kept for 72 h in the presence of the drug. At this time, some of the explants were collected in 100 ml H~2~O for NAD^+^ or NADP^+^ determination as described in [@bib7]. Other explants were cut, and the degeneration of the distal axons followed for another 72 h.

Online supplemental material
----------------------------

Fig. S1 shows the constructs used to generate Tg mice and the quantification of axon survival. Fig. S2 shows the survival of ATX3Wld^S^ and ΔN16Wld^S^ axons in vivo and in vitro. Fig. S3 shows the effects of increasing and decreasing NAD^+^. Videos 1 and 2 show the contraction of stimulated ATX3Wld^S^ and wild-type FDB muscle, respectively, 3 d after sciatic nerve lesion. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200807175/DC1>.
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